Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Supplementation in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
TCTR20260125008Phase 2Recruiting
- Sponsor
- Cardiac Electrophysiology Research and Training Center
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in chemotherapy-induced peripheral neuropathy (CIPN), breast cancer, sponsored by Cardiac Electrophysiology Research and Training Center. Started Oct 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)breast cancer
Beyond the preview
Go deeper on TCTR20260125008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260125008.